Literature DB >> 11337420

Is transmitted drug resistance in HIV on the rise? It seems so.

S J Little.   

Abstract

Mesh：

Year:  2001        PMID： 11337420      PMCID： PMC1120220          DOI： 10.1136/bmj.322.7294.1074

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed.

Authors:  A R Zolopa; R W Shafer; A Warford; J G Montoya; P Hsu; D Katzenstein; T C Merigan; B Efron
Journal:  Ann Intern Med       Date:  1999-12-07       Impact factor: 25.391

2.  Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

Authors:  S J Little; E S Daar; R T D'Aquila; P H Keiser; E Connick; J M Whitcomb; N S Hellmann; C J Petropoulos; L Sutton; J A Pitt; E S Rosenberg; R A Koup; B D Walker; D D Richman
Journal:  JAMA       Date:  1999 Sep 22-29       Impact factor: 56.272

3.  HIV-1 drug resistance in newly infected individuals.

Authors:  D Boden; A Hurley; L Zhang; Y Cao; Y Guo; E Jones; J Tsay; J Ip; C Farthing; K Limoli; N Parkin; M Markowitz
Journal:  JAMA       Date:  1999 Sep 22-29       Impact factor: 56.272

4.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

5.  Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

Authors:  M S Hirsch; F Brun-Vézinet; R T D'Aquila; S M Hammer; V A Johnson; D R Kuritzkes; C Loveday; J W Mellors; B Clotet; B Conway; L M Demeter; S Vella; D M Jacobsen; D D Richman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

6.  Transmission of antiretroviral-drug-resistant HIV-1 variants.

Authors:  S Yerly; L Kaiser; E Race; J P Bru; F Clavel; L Perrin
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

7.  Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom.

Authors: 
Journal:  BMJ       Date:  2001-05-05

8.  Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group.

Authors:  R T D'Aquila; V A Johnson; S L Welles; A J Japour; D R Kuritzkes; V DeGruttola; P S Reichelderfer; R W Coombs; C S Crumpacker; J O Kahn; D D Richman
Journal:  Ann Intern Med       Date:  1995-03-15       Impact factor: 25.391
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.